- We will be changing drug programs comprehensively - said Deputy Minister of Health Maciej Miłkowski during the Hearing of the Social Forum of Patients' Organizations and announced further good changes in hemat-oncology.
Large B-cell lymphoma (DLBCL) is the most common (about 25-30%) type of lymphoma. It is an aggressive and rapidly progressing high-grade neoplasm. Over 50 percent patients diagnosed with the disease were over 65 years of age. The goal of treatment is permanent cure, which is successful in nearly 70% of patients. sick. Unfortunately, the remaining 30 percent. In patients, the disease is resistant or has come back. Autolog...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
